You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

Guidelines & Advice

About Guidelines Email Guidelines Team

Immunotherapy

The guidelines and other documents available here provide recommendations related to immunotherapy for people affected by cancer in Ontario.

Displaying Guidelines

14 Items

T-Cell Engaging Antibodies: Management of Cytokine Release Syndrome (CRS) and Immune Effector-Associated Neurotoxicity Syndrome (ICANS)

Document Status: Current

Mar 2025

Treatment of Multiple Myeloma: ASCO–Ontario Health (Cancer Care Ontario) Living Guideline

Document Status: Current
ID: GL 6-A-2023-1
Version: 2

Updated

Jan 2026